Literature DB >> 21617049

Immunology. Regulatory T cells get their chance to shine.

Mitch Leslie.   

Abstract

Mesh：

Year:  2011        PMID： 21617049     DOI： 10.1126/science.332.6033.1020

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  29 in total

Review 1.  CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.

Authors:  Qizhi Tang; Jeffrey A Bluestone; Sang-Mo Kang
Journal:  J Mol Cell Biol       Date:  2011-12-14       Impact factor: 6.216

2.  High-dose cholecalciferol supplementation significantly increases peripheral CD4⁺ Tregs in healthy adults without negatively affecting the frequency of other immune cells.

Authors:  Barbara Prietl; Gerlies Treiber; Julia K Mader; Evelyne Hoeller; Michael Wolf; Stefan Pilz; Winfried B Graninger; Barbara M Obermayer-Pietsch; Thomas R Pieber
Journal:  Eur J Nutr       Date:  2013-09-03       Impact factor: 5.614

3.  The cAMP-Adenosine Feedback Loop Maintains the Suppressive Function of Regulatory T Cells.

Authors:  Wenru Su; Xiaoqing Chen; Wenjie Zhu; Jianfeng Yu; Weihua Li; Yingqi Li; Zhuang Li; Nancy Olsen; Dan Liang; Song Guo Zheng
Journal:  J Immunol       Date:  2019-08-16       Impact factor: 5.422

4.  Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region.

Authors:  Maura Rossetti; Roberto Spreafico; Suzan Saidin; Camillus Chua; Maryam Moshref; Jing Yao Leong; York Kiat Tan; Julian Thumboo; Jorg van Loosdregt; Salvatore Albani
Journal:  J Immunol       Date:  2014-12-01       Impact factor: 5.422

Review 5.  Immune biomarkers: the promises and pitfalls of personalized medicine.

Authors:  Joanna C D Willis; Graham M Lord
Journal:  Nat Rev Immunol       Date:  2015-03-27       Impact factor: 53.106

6.  Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease.

Authors:  Rikhia Chakraborty; Aruna Mahendravada; Serena K Perna; Cliona M Rooney; Helen E Heslop; Juan F Vera; Barbara Savoldo; Gianpietro Dotti
Journal:  Haematologica       Date:  2012-12-14       Impact factor: 9.941

Review 7.  Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.

Authors:  Tracy L McGaha; Lei Huang; Henrique Lemos; Richard Metz; Mario Mautino; George C Prendergast; Andrew L Mellor
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

8.  Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy.

Authors:  K Lee; V Nguyen; K-M Lee; S-M Kang; Q Tang
Journal:  Am J Transplant       Date:  2013-11-13       Impact factor: 8.086

Review 9.  Clinical perspectives for regulatory T cells in transplantation tolerance.

Authors:  Keli L Hippen; James L Riley; Carl H June; Bruce R Blazar
Journal:  Semin Immunol       Date:  2011-08-05       Impact factor: 11.130

Review 10.  HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies.

Authors:  Diana P English; Dana M Roque; Alessandro D Santin
Journal:  Mol Diagn Ther       Date:  2013-04       Impact factor: 4.074
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.